MEXICO IN VITRO DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Healthcare providers rely on a variety of tools to diagnose various diseases or conditions and guide treatment decisions. Among the most common and widely used are in vitro diagnostics (IVDs). IVD helps detect diseases or infections, and can be used to monitor overall health of the patient to help treat, cure, or prevent diseases. IVD is used as a diagnostic tool by clinicians for faster diagnosis and to ensure timely treatment for patients. IVD medical devices are tests performed on biological samples taken from the human body to determine overall health.

Market Dynamics

Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases is expected to boost the growth of the Mexico in-vitro diagnostics market during the forecast period. The number and proportion of people aged 65 years and older in the population is increasing. For instance, according to the AARP International (Mexico), Mexico's population age 65 and older is expected to grow by around 277% from 8.2 million in 2015 to reach over 30 million by 2050. Mexico's healthy life expectancy at birth is estimated by WHO at 68 years, which is nine years less than the total life expectancy for the country at birth. Despite the slight increase in healthy life expectancy, population is expected to face increasing chronic disease, disability, and morbidity due to lifestyle trends resulting in obesity and diabetes.

Key features of the study

• This report provides in-depth analysis of the Mexico in-vitro diagnostics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the Mexico in-vitro diagnostics market based on the following parameters, such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include BioMerieux SA, Thermo Fisher Scientific Inc., Siemens Healthineers, Sysmex Corporation, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, and Becton, Dickinson and Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Mexico in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Mexico in-vitro diagnostics market.

Market Segmentation

• By Technique Insights (Revenue, US$ Mn, 2020 - 2033)
  • Clinical Chemistry
  • Molecular Diagnostics
  • Immuno Diagnostics
  • Hematology
  • Other Techniques
• By Product Insights (Revenue, US$ Mn, 2020 - 2033)
  • Instrument
  • Reagent
  • Other Products
• By Usability Insights (Revenue, US$ Mn, 2020 - 2033)
  • Disposable IVD Devices
  • Reusable IVD Devices
• By Application Insights (Revenue, US$ Mn, 2020 - 2033)
  • Infectious Diseases
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Diabetes Nephrology
  • Other Applications
• By End User Insights (Revenue, US$ Mn, 2020 - 2033)
  • Diagnostic laboratories
  • Hospitals and Clinics
  • Other End Users
• Key Players
  • Danaher Corporation
  • BioMerieux SA
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Hoffmann-La Roche AG
  • Becton, Dickinson and Company